Western Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Buy
7,949
+4,068
+105% +$570K 0.04% 414
2025
Q4
$476K Buy
3,881
+12
+0.3% +$1.46K 0.02% 527
2025
Q3
$429K Buy
3,869
+6
+0.2% +$682 0.02% 480
2025
Q2
$428K Buy
3,863
+23
+0.6% +$2.45K 0.03% 456
2025
Q1
$430K Buy
3,840
+30
+0.8% +$3.1K 0.03% 434
2024
Q4
$352K Sell
3,810
-4,662
-55% -$420K 0.02% 474
2024
Q3
$710K Buy
8,472
+4,762
+128% +$363K 0.04% 366
2024
Q2
$255K Sell
3,710
-1,630
-31% -$109K 0.02% 548
2024
Q1
$391K Sell
5,340
-3,283
-38% -$252K 0.03% 428
2023
Q4
$699K Buy
8,623
+576
+7% +$44.8K 0.05% 340
2023
Q3
$603K Buy
8,047
+5,361
+200% +$412K 0.05% 343
2023
Q2
$207K Buy
2,686
+7
+0.3% +$558 0.02% 605
2023
Q1
$222K Buy
2,679
+7
+0.3% +$580 0.02% 585
2022
Q4
$229K Sell
2,672
-6,271
-70% -$497K 0.02% 540
2022
Q3
$554K Sell
8,943
-673
-7% -$42.4K 0.03% 447
2022
Q2
$596K Buy
9,616
+1,039
+12% +$64.3K 0.03% 425
2022
Q1
$510K Buy
8,577
+2,725
+47% +$174K 0.02% 526
2021
Q4
$426K Buy
+5,852
New +$403K 0.04% 362
2021
Q2
$323K Buy
+4,693
New +$313K 0.03% 474
2020
Q4
Sell
-3,692
Closed -$234K 479
2020
Q3
$234K Buy
3,692
+8
+0.2% +$555 0.04% 380
2020
Q2
$283K Buy
3,684
+528
+17% +$40.5K 0.05% 328
2020
Q1
$236K Buy
+3,156
New +$218K 0.05% 313
2019
Q1
Sell
-4,220
Closed -$267K 385
2018
Q4
$267K Buy
+4,220
New +$295K 0.07% 270

Other funds holding GILD

Western Wealth Management's GILD Position: Q1 2026 in Review

Western Wealth Management increased its Gilead Sciences (GILD) stake by 105% in Q1 2026, buying an estimated $570K and bringing the position to 7,949 shares worth $1.11M. The position accounts for 0.04% of the portfolio, ranked #414.

Western Wealth Management first reported a position in GILD in Q4 2018 and has held it in 23 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Western Wealth Management held 7,949 shares of Gilead Sciences worth $1.11M as of Q1 2026.
  • Western Wealth Management bought 4,068 Gilead Sciences shares in Q1 2026, an estimated $570K.
  • Gilead Sciences made up 0.04% of Western Wealth Management's portfolio in Q1 2026, its #414 holding.
  • Western Wealth Management first reported a position in Gilead Sciences in Q4 2018 and has held it in 23 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Western Wealth Management's 13F filing for Q1 2026, filed 19 May 2026.